For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a million people each year in the U.S. Now, a breakthrough may be within reach.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

This cat vaccine market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market ...

Just in time for tick season, new research is shining a light on how animals develop resistance to tick bites, which points ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

Lyme disease, a disease transmitted when deer ticks feed on infected animals like deer and rodents, and then bite humans, impacts nearly half a million individuals in the U.S. annually.

Evidence increasingly suggests that infections play a critical role in triggering or exacerbating many chronic ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

Revenues from our growing commercial business help fuel the continued advancement of our vaccine pipeline. This includes the only Lyme disease vaccine candidate in advanced clinical development ...

A Northwestern University study reveals that piperacillin, a common antibiotic, effectively treats Lyme disease in mice at a ...